Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-07-10
2007-07-10
Carlson, Karen Cochrane (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000, C530S351000
Reexamination Certificate
active
10490064
ABSTRACT:
Disclosed are compositions and methods related to osteoblasts, osteoclasts, and osteoclast lacunae.
REFERENCES:
Pun et al. Aug. 2000; Anabolic effects of basic fibroblast growth factor in tibial diaphysis of ovariectomized rats. Bone. 27(2): 197-202.
Hagihara et al. 2000; Glypican-4 is an FGF2-binding heparin sulfate proteoglycan expressed in neural precursor cells. Developmental Dynamics. 219: 353-367.
Dunstan et al. 1999; Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats. J. Bone and Mineral Research. 14(6): 953-959.
Chikazu et al. Oct. 6, 2000: Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase. J. Biol. Chem. 275(40): 31444-31450.
Mancilla et al. 1998; Effects of fibroblast growth factor-2 on longitudinal bone growth. Endocrinology. 139(6): 2900-2904.
Sheu et al. 2003; A phage displat technique identifies a novel regulator of cell differentiation. J. Biol. Chem. 278(1): 438-443.
Marie et al. 1990 ; Effects of epidermal growth factor on bone formation and resoption in vivo. Endocrinol. Metab. 21: E275-E281.
Canalis et al. 1979 ; Effects of epidermal growth factor on bone formation in vitro. Endocrinology 104(4): 862-869.
Bradford et al. Feb., 2000; The effect of bone morphogenetic protein-7 on the expression of type I inositol 1, 4, 5-triphophate receptor in G292 osteosarcoma cells and primaty osteoblast cutures. Archives of Oral Biology 45(2): 159-166.
Abe et al., Etidronate inhibits human osteoblast apoptosis by inhibition of pro-apoptotic factor(s) produced by activated T cells. J Lab Clin Med. Nov. 2000;136(5):344-54.
Al Kawas et al., Immunolocalization of the cation-independent mannose 6-phosphate receptor and cathepsin B in the enamel organ and alveolar bone of the rat incisor. Calcif Tissue Int. Sep. 1996;59(3):192-9.
Artmann et al., Micropipette aspiration of human erythrocytes induces echinocytes via membrane phospholipid translocation. Biophys J. Mar. 1997;72(3):1434-41.
Ash et al. (1980) Giant lysosomes, a cytoplasmic marker in osteoclasts of beige mice. Journal of Pathology. 130:237-45.
Barancik et al., Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol. Mar. 2000;35(3):474-83.
Baron (1989) Molecular mechanisms of bone resorption by the osteoclast. Anatomical Record. 224:317-24.
Baron et al. (1986) Kinetic and cytochemical indentification of osteoclast precursors and their differentiation into multinucleated osteoclasts. American Journal of Pathology. 122:363-78.
Baron et al., Polarized secretion of lysosomal enzymes: co-distribution of cation-independent mannose-6-phosphate receptors and lysosomal enzymes along the osteoclast exocytic pathway. J Cell Biol. Jun. 1988;106(6):1863-72.
Baron et al., Selective Internalization Of The Apical Plasma Membrane And Rapid Redistribution Of Lysosomal Enzymes And Mannose 6-Phosphate Receptors During Osteoclast Inactivation By Calcitonin. J Cell Sci. Nov. 1990;97 ( Pt 3):439-47.
Baylink et al., “Coupling Factor.” Adv Exp Med Biol. 1982;151:409-21.
Bikle And Halloran, The Response Of Bone To Unloading. Bone Miner Metab. 1999;17(4):233-44.
Blaine et al., “Modulation of the production of cytokines in titanium-stimulated human peripheral blood monocytes by pharmacological agents. The role of cAMP-mediated signaling mechanisms.” J Bone Joint Surg Am. Oct. 1997;79(10):1519-28.
Blaine et al., Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am. Aug. 1996;78(8):1181-92.
Blair et al., “Recent advances toward understanding osteoclast physiology.” Clin Orthop. Sep. 1993;(294):7-22.
Bonewald et al., “Stimulation of matrix vesicle enzyme activity in osteoblast-like cells by 1,25(OH)2D3 and transforming growth factor beta (TGF beta).” Bone Miner. May 1992;17(2):139-44.
Bronckers et al., DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling. J Bone Miner Res. Sep. 1996;11(9):1281-91.
Burger and Klein-Nulend, Mechanotransduction in bone—role of the lacuno-canalicular network. FASEB J. 1999;13 Suppl:S101-12.
Cheifetz et al., Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro. Connect Tissue Res. 1996;35(1-4):71-8.
Chen et al., A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature. Oct. 12, 1995;377(6549):548-52.
Choy and Derynck, The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem. Nov. 20, 1998;273(47):31455-62.
Chung et al., Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Biochem Biophys Res Commun. Nov. 1999;265(1):246-51.
Delaisse et al. (1985) Bisphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion. Life Sciences. 37:2291-6.
Epker and Frost, “The nature of bone resorption and formation in normalcy and disease.” Henry Ford Hosp Med J. 1968 Spring;16(1):29-39.
Evans et al.. Future of adenoviruses in the gene therapy of arthritis. Arthritis Research. 3(3):142-6, 2001.
Franzoso et al., Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. Dec. 15, 1997;11(24):3482-96.
Frost, Journal of Bone & Joint Surgery-American vol. 48 (6): 1192-203, 1966.
Ghivizzani et al.. Gene therapy approaches for treating rheumatoid arthritis. Clinical Orthopaedics & Related Research. (379 Suppl):S288-99, 2000.
Griswold-Prenner, et al., Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol Cell Biol. Nov. 1998;18(11):6595-604.
Grzesik and Robey, Bone matrix RGD glycoproteins: immunolocalization and interaction with human primary osteoblastic bone cells in vitro. J Bone Miner Res. Apr. 1994;9(4):487-96.
Harris and Heaney, “Skeletal renewal and metabolic bone disease.” N Engl J Med. Jan. 30, 1969;280(5):253-9 contd.
Harris and Heaney, “Skeletal renewal and metabolic bone disease.” N Engl J Med. Feb. 6, 1969;280(6):303-11 concl.
Harris et al., Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res. Jun. 1994;9(6):855-63.
Hayman et al., Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development. Oct. 1996;122(10):3151-62.
Hayman et al., Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo. J Anat. Apr. 2000;196 ( Pt 3):433-41.
Hirano et al., Does suppression of bone turnover impair mechanical properties by allowing microdamage accumulation? Bone. Jul. 2000;27(1):13-20.
Hock et al., Osteoblast apoptosis and bone turnover. J Bone Miner Res. Jun. 2001;16(6):975-84.
Howard et al., Parathyroid hormone stimulates bone formation and resorption in organ culture: evidence for a coupling mechanism. Proc Natl Acad Sci U S A. May 1981;78(5):3204-8.
Howard GA. et al. , “Coupled bone metabolism in vitro: embryonic chick limbs in organ culture.” Prog Clin Biol Res. 1982;101:259-74.
Humphrey and Enoch, Sum1, a highly conserved WD-repeat protein, suppresses S-M checkpoint mutants and inhibits the osmotic stress cell cycle response in fission yeast. Genetics. Apr. 1998;148(4):1731-42.
Ionescu et al. PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J Biol Chem. Apr. 13, 2001;276(15):11639-47. Epub Jan. 2, 2001.
Ishibashi et al., Quantification of the expression le
Carlson Karen Cochrane
Needle & Rosenberg P.C.
University of Rochester
LandOfFree
Compositions and methods involved in bone growth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods involved in bone growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods involved in bone growth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3729793